Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.68B |
| 2 |
Synchrony
SYF
|
+$441M |
| 3 |
Meta Platforms (Facebook)
META
|
+$370M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$349M |
| 5 |
Comcast
CMCSA
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$783M |
| 2 |
Morgan Stanley
MS
|
+$518M |
| 3 |
Lowe's Companies
LOW
|
+$474M |
| 4 |
Visa
V
|
+$425M |
| 5 |
Netflix
NFLX
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.01% |
| 2 | Technology | 4.76% |
| 3 | Consumer Discretionary | 3.82% |
| 4 | Industrials | 3.81% |
| 5 | Communication Services | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Krystal Biotech
KRYS
$9.83B
| $6.96M | ﹤0.01% |
+335,029
| New | +$7.01M |
|
2202
PUT
Check Point Software Technologies
CHKP
$13.4B
| $6.96M | ﹤0.01% |
67,800
+6,400
| +10% | +$703K |
|
2203
CALL
Madison Square Garden
MSGS
$9.8B
| $6.96M | ﹤0.01% |
36,452
-28,601
| -44% | -$5.56M |
|
2204
Sonos
SONO
$1.93B
| $6.96M | ﹤0.01% |
708,708
+332,496
| +88% | +$4.17M |
|
2205
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.36B
| $6.96M | ﹤0.01% |
211,500
+122,500
| +138% | +$5.22M |
|
2206
Alkermes
ALKS
$8.23B
| $6.95M | ﹤0.01% |
235,507
+149,798
| +175% | +$5.52M |
|
2207
Paylocity
PCTY
$7.87B
| $6.95M | ﹤0.01% |
115,436
+5,606
| +5% | +$359K |
|
2208
Valmont Industries
VMI
$9.56B
| $6.95M | ﹤0.01% |
62,648
+8,069
| +15% | +$1.01M |
|
2209
CALL
Atlassian
TEAM
$41.2B
| $6.95M | ﹤0.01% |
78,100
+6,500
| +9% | +$515K |
|
|
SINA
2210
CALL
DELISTED
Sina Corp
SINA
| $6.95M | ﹤0.01% |
129,500
-82,200
| -39% | -$5.08M |
|
2211
Cemex
CX
$16B
| $6.94M | ﹤0.01% |
1,440,425
+1,293,114
| +878% | +$6.9M |
|
2212
iShares MSCI Europe Financials ETF
EUFN
$4.31B
| $6.94M | ﹤0.01% |
409,537
+242,925
| +146% | +$4.47M |
|
|
TARO
2213
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $6.94M | ﹤0.01% |
82,016
+37,088
| +83% | +$3.58M |
|
2214
PUT
Franco-Nevada
FNV
$45.2B
| $6.94M | ﹤0.01% |
98,900
-24,600
| -20% | -$1.64M |
|
|
LTC
2215
LTC Properties
LTC
$2.17B
| $6.93M | ﹤0.01% |
166,366
-5,365
| -3% | -$235K |
|
2216
PUT
DaVita
DVA
$11.5B
| $6.93M | ﹤0.01% |
134,700
-41,100
| -23% | -$2.63M |
|
2217
Cinemark Holdings
CNK
$4.33B
| $6.93M | ﹤0.01% |
193,539
-770,845
| -80% | -$30.5M |
|
|
IMMU
2218
PUT
DELISTED
Immunomedics Inc
IMMU
| $6.92M | ﹤0.01% |
485,100
+170,600
| +54% | +$3.39M |
|
|
MMP
2219
PUT
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $6.91M | ﹤0.01% |
121,100
+14,400
| +13% | +$889K |
|
|
FITB
2220
PUT
Fifth Third Bancorp
FITB
$52.7B
| $6.9M | ﹤0.01% |
293,200
+100,300
| +52% | +$2.64M |
|
2221
CALL
Cencora
COR
$59.9B
| $6.9M | ﹤0.01% |
92,700
-146,900
| -61% | -$12.7M |
|
2222
PUT
iShares US Transportation ETF
IYT
$2.28B
| $6.9M | ﹤0.01% |
167,200
-14,000
| -8% | -$646K |
|
|
CZR
2223
CALL
DELISTED
Caesars Entertainment Corporation
CZR
| $6.9M | ﹤0.01% |
1,015,700
+173,300
| +21% | +$1.46M |
|
2224
PUT
iShares MSCI Australia ETF
EWA
$1.45B
| $6.89M | ﹤0.01% |
357,800
+308,700
| +629% | +$6.34M |
|
|
WUBA
2225
PUT
DELISTED
58.com Inc
WUBA
| $6.88M | ﹤0.01% |
126,900
+1,900
| +2% | +$116K |
|
Similar funds
Ken Griffin's Q4 2018 Portfolio in Review
As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.
- Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
- Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
- Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
- Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
- Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
- Ken Griffin opened 1,236 new positions and closed 1,371 in Q4 2018.
- Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.